Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19745172rdf:typepubmed:Citationlld:pubmed
pubmed-article:19745172lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0038454lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0360714lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0201950lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C1550594lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0428466lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C1548760lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C1547300lld:lifeskim
pubmed-article:19745172lifeskim:mentionsumls-concept:C0580822lld:lifeskim
pubmed-article:19745172pubmed:issue11lld:pubmed
pubmed-article:19745172pubmed:dateCreated2009-10-27lld:pubmed
pubmed-article:19745172pubmed:abstractTextLaboratory experiments suggest statins reduce stroke severity and improve outcomes. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial was a placebo-controlled, randomized trial designed to determine whether treatment with atorvastatin reduces strokes in subjects with recent stroke or transient ischemic attack (n=4731). We analyzed SPARCL trial data to determine whether treatment favorably shifts the distribution of severities of ischemic cerebrovascular outcomes.lld:pubmed
pubmed-article:19745172pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19745172pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19745172pubmed:languageenglld:pubmed
pubmed-article:19745172pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19745172pubmed:citationSubsetIMlld:pubmed
pubmed-article:19745172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19745172pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19745172pubmed:statusMEDLINElld:pubmed
pubmed-article:19745172pubmed:monthNovlld:pubmed
pubmed-article:19745172pubmed:issn1524-4628lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:WelchAAlld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:MichaelKKlld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:SillesenHenri...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:AmarencoPierr...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:GoldsteinLarr...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:HennericiMich...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:MessigMichael...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:ZivinJustinJlld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:ZweiflerRicha...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:CallahanAlfre...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:Stroke...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:MacLeodMary...lld:pubmed
pubmed-article:19745172pubmed:authorpubmed-author:AltafullahIrf...lld:pubmed
pubmed-article:19745172pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19745172pubmed:volume40lld:pubmed
pubmed-article:19745172pubmed:ownerNLMlld:pubmed
pubmed-article:19745172pubmed:authorsCompleteYlld:pubmed
pubmed-article:19745172pubmed:pagination3526-31lld:pubmed
pubmed-article:19745172pubmed:dateRevised2010-3-4lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:meshHeadingpubmed-meshheading:19745172...lld:pubmed
pubmed-article:19745172pubmed:year2009lld:pubmed
pubmed-article:19745172pubmed:articleTitleStatin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.lld:pubmed
pubmed-article:19745172pubmed:affiliationDepartment of Medicine, Division of Neurology, Duke University Medical Center, Durham, NC 27710, USA. golds004@mc.duke.edulld:pubmed
pubmed-article:19745172pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19745172pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:19745172pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:19745172pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:19745172pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19745172lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19745172lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19745172lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19745172lld:pubmed